Tag: DENV-2

Apr 19, 2026

• vector
• mosquito
• Aedes-aegypti
• transmission
• urban
• salivary-gland
• DENV-2
• Asian-genotype

Apr 19, 2026

• Latin-America
• Americas
• Caribbean
• Cuba
• Nicaragua
• Brazil
• Paraguay
• DENV-2
• DENV-3
• DENV-4
• epidemic
• endemic
• autoimmunity
• MAS

Apr 19, 2026

• Southeast-Asia
• regional
• endemic
• Thailand
• Singapore
• Philippines
• Vietnam
• Cambodia
• DENV-1
• DENV-2
• DENV-3
• DENV-4
• hyperendemic
• paediatric-dengue
• DHF
• autoimmunity
• PAIgG
• PAIgM
• thrombocytopenia
• anti-platelet
• anti-endothelial
• ADE
• anti-prM
• asymptomatic

Apr 19, 2026

• Vietnam
• Southeast-Asia
• endemic
• DHF
• DSS
• pediatric
• infants
• Ho-Chi-Minh-City
• primary-infection
• secondary-infection
• anti-platelet
• anti-endothelial
• thrombomodulin
• NCKU-collaboration
• DENV-2
• DENV-3
• DENV-4
• NS1-mimicry
• PDI
• autoimmunity

Apr 18, 2026

• neurological
• ADEM
• encephalomyelitis
• encephalitis
• Guillain-Barre
• GBS
• CNS
• neuropathogenesis
• DENV-2
• DENV-3
• post-infectious
• molecular-mimicry
• retinal-vasculitis
• immune-complex
• ophthalmological

Apr 17, 2026

• serotype
• DENV-2
• Asian-genotype
• virulence
• ADE
• secondary-infection
• Cuba
• CNS-invasion
• neuropathogenesis
• anti-platelet
• IgM
• autoantibody-cross-serotype
• anti-prM
• cross-reactivity
• NS3
• salivary-gland-replication